Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Joint Bone Spine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 12 octobre 2019
Doi : 10.1016/j.jbspin.2019.08.002
Received : 9 July 2019 ;  accepted : 29 August 2019
Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: A Multicenter Study
 

Martin Michaud a, b, , Olivier Lidove b, c, Boris Bienvenu b, d, Laurent Chiche b, e, Geoffrey Urbanski f

TOCIMAI Investigators Groupa, b, c, d, e, f, g, h, i, j, k, 1

  TOCIMAI Investigators Group: Thomas Sené, Frédérique Retornaz, Laurent Alric, Laurent Sailler, Arsène Mekinian, Jean Thomas Giraud, Léo Caudrelier, Slim Lassoued, Florian Catros, Sophie Ancellin, Francis Gaches.

a Department of Internal Medicine, hôpital Joseph-Ducuing, 15, rue Varsovie, 31076 Toulouse, France 
b Groupe de recherche des internistes FEHAP (GRIF), Paris, France 
c Department of Internal Medicine, groupe hospitalier Diaconesses Croix Saint Simon, Paris, France 
d Department of Internal Medicine, Saint Joseph Hospital, Marseille, France 
e Department of Internal Medicine, hôpital européen, Marseille, France 
f Department of Internal Medicine, Angers University Hospital, Angers, France 
g Toulouse University hospital, Internal Medicine, Toulouse, France 
h Tarbes Hospital, Internal Medicine, Tarbes, France 
i Cahors Hospital, Internal Medicine, Cahors, France 
j Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 
k Harvard Medical School, Boston, Massachusetts 

Corresponding author at: Department of Internal Medicine, hôpital Joseph-Ducuing, 15, rue Varsovie, 31076 Toulouse, France.Department of Internal Medicine, hôpital Joseph-Ducuing15, rue VarsovieToulouse31076France

Keywords : Autoimmune Diseases, Tocilizumab, Treatment, Adult Onset Still's Disease, Polymyalgia Rheumatica


1  TOCIMAI Investigators Group: Thomas Sené, Frédérique Retornaz, Laurent Alric, Laurent Sailler, Arsène Mekinian, Jean Thomas Giraud, Léo Caudrelier, Slim Lassoued, Florian Catros, Sophie Ancellin, Francis Gaches.


© 2019  Société française de rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline